ArticleDiabetologia2020

Luseogliflozin increases beta cell proliferation through humoral factors that activate an insulin receptor- and IGF-1 receptor-independent pathway.

Jun Shirakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.